A Bone Targeting Nanoparticle Loaded OGP to Restore Bone Homeostasis for Osteoporosis Therapy
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202300560 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Shiqing Ma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, The Second Hospital of Tianjin medical university, Tianjin, 300211, China. Hauptthemen laut MEDLINE: Nanoparticles, Osteoporosis, Homeostasis, Peptides. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Clinical Research Special Fund of Wu Jieping Medical Foundation, Scientific Foundation of Tianjin Education Commission.
Abstract (Originalsprache)
Restoring bone homeostasis is the key to the treatment of osteoporosis. How to increase osteogenic ability or inhibit osteoclast activity has always been a topic of great concern. In recent years, short peptides with biological activity have received great attention in bone repair. However, the application of short peptides is still limited due to the lack of a stable and targeted delivery system. Poly(lactic‐ co ‐glycolic acid) (PLGA) nanoparticles modified by alendronate (AL) to transport osteogenic peptides (OGP) (AL‐PLGA@P NPs) are designed. Benefiting from the high affinity of AL for hydroxyapatite, AL‐PLGA@P NPs have the ability to target bone. In this delivery system, OGP that promotes osteogenesis synergizes with AL, which inhibits osteoclasts, to regulate bone homeostasis, which gives them more advantages in the treatment of osteoporosis. The data shows that nanoparticles can selectively deliver peptides to the bone surface without systemic toxicity. Moreover, nanoparticles can upregulate osteogenesis‐related factors (ALP, Runx‐2, and BMP2) and downregulate osteoclast‐related factors (TRAP and CTSK) in vitro. With AL‐PLGA@P NPs, bone microarchitecture and bone mass are improved in ovariectomized osteoporosis rats. Therefore, this study proposes a novel osteoporosis‐based drug system that effectively improves bone density.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, The Second Hospital of Tianjin medical university, Tianjin, 300211, China.
- School and Hospital of Stomatology, Tianjin Medical University, Tianjin, 30070, China.
- Beijing Biosis Healing Biological Technology Co. Ltd., Beijing, 102600, China.
- Department of Orthopaedics, The Fourth Medical Centre, Chinese PLA General Hospital, Beijing, 100048, China.
ORCID-Profile: Shendan Xu, Yonglan Wang
Förderung
- National Natural Science Foundation of China
- Clinical Research Special Fund of Wu Jieping Medical Foundation
- Scientific Foundation of Tianjin Education Commission
- Science and Technology Project of Tianjin Health Committee
- Natural Science Foundation of Tianjin
- Scientific Foundation of Hospital of Stomatology, Tianjin Medical University
- Natural Science Foundation of Tianjin City
Zitieren
APA
Ma, S., Xu, S., Li, M., Du, Y., Tian, G., Deng, J., Zhang, W., Wei, P., Zhao, B., Zhang, X., Liu, Z., & Wang, Y. (2023). A Bone Targeting Nanoparticle Loaded OGP to Restore Bone Homeostasis for Osteoporosis Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300560
Vancouver
Ma S, Xu S, Li M, Du Y, Tian G, Deng J, et al. A Bone Targeting Nanoparticle Loaded OGP to Restore Bone Homeostasis for Osteoporosis Therapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300560
BibTeX
@article{Ma2023,
author = {Ma, Shiqing and Xu, Shendan and Li, Minting and Du, Yaqi and Tian, Guangjie and Deng, Jiayin and Zhang, Wenyi and Wei, Pengfei and Zhao, Bo and Zhang, Xuesong and Liu, Zihao and Wang, Yonglan},
title = {A Bone Targeting Nanoparticle Loaded OGP to Restore Bone Homeostasis for Osteoporosis Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202300560}
}
EUVIMED